Thursday 08 June 2023 - 11:01
In Business 43 Years - Since 1980
NOTE: all of our usual telephone and FAX systems are currently down due to a dispute between our landlord and Verizon. We are working to remedy this situation and get our phones back on ASAP.
In the meantime, please use this mobile phone number: 978-715-9327, and this fax number: 781-491-0695.
Thank you for your patience as we work through this unfortunate outage caused by a dispute beyond our control.
Sale: 25% Off !!
For Online Shopping Cart Orders Only
In-Stock Sizes Only - Limited Time Only
See Check-out Page For Further Details
FREE SHIPPING TO THE U.S. AND 32 OTHER COUNTRIES! [Read more].
N-9055 Nintedanib, Ethanesulfonate Salt, >99%
Synonyms : [BIBF1120 Esylate] [Intedanib Esylate] [Nintedanib Esylate]
Related Terms : [OFEV] [Vargatef]
- Size
- US $
- €
- £
- ¥
- 25 mg
- 38
- 35
- 30
- 5,300
- In stock
- 50 mg
- 49
- 45
- 39
- 6,900
- In stock
- 100 mg
- 64
- 59
- 51
- 8,900
- In stock
- 200 mg
- 85
- 79
- 68
- 11,900
- In stock
- 500 mg
- 144
- 134
- 115
- 20,100
- In stock
- 1 g
- 199
- 185
- 159
- 27,800
- In stock
- 2 g
- 346
- 322
- 277
- 48,400
- In stock
- 5 g
- 690
- 643
- 554
- 96,500
- In stock
- 10 g
- 1,160
- 1,082
- 931
- 162,200
- In stock
Note: Our Euro, Pound, and Yen prices are revised regularly to account for currency exchange rate fluctuations.
- M.W. 649.76
- C31H33N5O4•C2H6O3S
- [656247-18-6]
- M.I. 15: 5031
Storage: Store at or below -20 ºC. Solubility: Soluble in DMSO at 25 mg/mL with warming; soluble in ethanol at 8 mg/mL with warming; soluble in water at 25 mg/mL with warming; buffers, serum, or other additives may increase or decrease the aqueous solubility. Disposal: A.
- This research compound is the ethanesulfonate salt form of nintedanib; please see the other form of this product, Nintedanib, Free Base, Cat. No. N-9077, for further technical information about both of these research compounds.
- This nintedanib product is the ethanesulfonate salt, whose CAS number is given above. The CAS number of the Nintedanib, Free Base form is 656247-17-5.
- Nintedanib Ethanesulfonate Salt is the active ingredient in the drug product sold under the trade name Vargatef®. This drug has been used in human clinical trials for patients with non-small cell lung, colorectal, uterine, endometrial, ovarian, and cervical cancer and multiple myeloma. NOTE: THE NINTEDANIB, ETHANESULFONATE SALT SOLD BY LC LABORATORIES FOR RESEARCH IS NOT VARGATEF®, AND IS NOT FOR HUMAN USE.
- Sold for laboratory or manufacturing purposes only; not for human, veterinary, food, or household use.
- This product is offered for R&D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (vi) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (vii) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (viii) such similar laws and rules as may apply in various other countries.
- Not available in some countries; not available to some institutions; not available for some uses.
